Article Details

USA FDA Grants Fast Track Designation to ReAlta Life Sciences' Lead Compound RLS ...

Retrieved on: 2022-06-23 13:12:33

Tags for this article:

Click the tags to see associated articles and topics

USA FDA Grants Fast Track Designation to ReAlta Life Sciences' Lead Compound RLS .... View article details on hiswai: https://www.biospace.com/article/releases/usa-fda-grants-fast-track-designation-to-realta-life-sciences-lead-compound-rls-0071-for-the-treatment-of-hypoxic-ischemic-encephalopathy-in-neonates/

Excerpt

RLS-0071 is a 15 amino acid peptide that both inhibits humoral ... ReAlta Life Sciences, Inc. is a clinical-stage, rare disease biotech company ...

Article found on: www.biospace.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up